infectious disease, cancer/oncology, neurology, immunology, cardiology
Showing 1 - 25 of >10,000
MDS, Acute Leukemia Trial in Germany (CIK-Cells)
Active, not recruiting
- Myelodysplastic Syndromes
- Acute Leukemia
-
Heidelberg, Baden-Württemberg, Germany
- +4 more
Mar 31, 2022
Infectious Disease, Tumors, Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism
Recruiting
- Infectious Disease
- +20 more
-
Arlington Heights, IllinoisAnova Enterprises, Inc.
May 13, 2022
Preterm Birth, Pediatric Cancer, Hirschsprung Disease Trial in Copenhagen, Hillerød, Lund (e-health device with application)
Enrolling by invitation
- Preterm Birth
- +5 more
- e-health device with application
-
Copenhagen, Denmark
- +5 more
Dec 7, 2022
Understanding CARdiac Events in Breast Cancer
Recruiting
- Breast Cancer
- +5 more
-
Galway, Ireland
- +3 more
Jun 27, 2023
Genetic Susceptibility to Severe Infections
Not yet recruiting
- Infectious Disease
- Blood samples drawing
- Skin biopsy
- (no location specified)
Oct 20, 2023
Xerostomia Following Radiotherapy Trial in Copenhagen (Stem cells, Placebo)
Recruiting
- Xerostomia Following Radiotherapy
- Stem cells
- Placebo
-
Copenhagen, DenmarkChristian von Buchwald, MD, DMSc, Professor
Feb 26, 2021
CNS Infections, CNS Complication, Infectious Disease of Nervous System Trial in Worldwide
Recruiting
- Central Nervous System Infections
- +5 more
-
Westmead, Australia
- +16 more
Jun 1, 2022
Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Giredestrant,
Recruiting
- Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
- Giredestrant
- +5 more
-
Anchorage, Alaska
- +386 more
Jan 30, 2023
Lung Cancer Trial in Australia, Canada, United States (lobectomy, segmentectomy or wedge resection)
Active, not recruiting
- Lung Cancer
- lobectomy
- segmentectomy or wedge resection
-
Birmingham, Alabama
- +385 more
Nov 17, 2022
Breast Tumor, Prostatic Tumor, Colorectal Tumors Trial in United States (AH-HA Tool in the EPIC EHR)
Enrolling by invitation
- Breast Neoplasm
- +5 more
- AH-HA Tool in the EPIC EHR
-
Fort Smith, Arkansas
- +11 more
Dec 8, 2022
Breast Cancer Trial in Milan (CT scan and blood sample collection)
Recruiting
- Breast Cancer
- CT scan and blood sample collection
-
Milan, ItalyIRCCS Centro Cardiologico Monzino
Mar 17, 2023
Chronic GVHD Trial in Worldwide (Ibrutinib)
Active, not recruiting
- Chronic Graft Versus Host Disease
-
Duarte, California
- +47 more
Jul 15, 2022
Patterns and Disease Control in cHL and sALCL in Routine
Completed
- Hodgkin Disease
- Lymphoma, Large-cell, Anaplastic
-
Astrakhan, Russian Federation
- +49 more
Dec 19, 2022
Squamous NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody,
Completed
- Squamous Non-Small Cell Lung Cancer
- Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (anti-PD-L1) antibody
- +3 more
-
Chandler, Arizona
- +241 more
Mar 17, 2022
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
Burnout, Professional Trial in Semarang (Traditional Music Therapy)
Not yet recruiting
- Burnout, Professional
- Traditional Music Therapy
-
Semarang, Jawa Tengah, IndonesiaRSUP dr. Kariadi Semarang
Nov 12, 2023
Tumors Trial in Worldwide (Gene-modified (GM) T cell therapy)
Recruiting
- Neoplasms
- Gene-modified (GM) T cell therapy
-
Birmingham, Alabama
- +173 more
Aug 1, 2022
Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data
Recruiting
- Breast Cancer
- +4 more
- anonymized data collection during programmed surveillance clinical follow up
-
Weston, FloridaCleveland Clinic Florida
Oct 27, 2022
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Lymphoma, B-Cell
- +4 more
-
Burbank, California
- +90 more
Mar 31, 2022
Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))
Recruiting
- Hepatitis C Virus (HCV)
- Glecaprevir/Pibrentasvir (GLE/PIB)
-
Chandler, Arizona
- +62 more
Aug 8, 2022
BK Virus Disease After Allogeneic Hematopoietic-cell
Active, not recruiting
- BK Virus Infection
- Symptom index questionnaire
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 27, 2023
International CIPN Assessment and Validation Study
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Quality of Life
- outcome measures for CIPN testing
-
Birmingham, Alabama
- +29 more
Apr 27, 2022
